首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Catheter-based decompression of the left atrium in patients with hypoplastic left heart syndrome and restrictive atrial septum is safe and effective.
【24h】

Catheter-based decompression of the left atrium in patients with hypoplastic left heart syndrome and restrictive atrial septum is safe and effective.

机译:发育不良的左心综合征和限制性房间隔患者的左心导管导管减压术是安全有效的。

获取原文
获取原文并翻译 | 示例
           

摘要

Infants with hypoplastic left heart syndrome (HLHS) and restrictive or intact atrial septum (rAS) present with cyanosis, pulmonary edema, and are critically ill. A previous report from our institution on emergent Norwood for HLHS with rAS showed 10% survival. We hypothesized that transcatheter left atrial (LA) decompression in HLHS with rAS would safely and effectively relieve LA hypertension, improve oxygenation, and improve Norwood survival. Between 1996 and 2004, 30 patients with HLHS and rAS underwent cardiac catheterization for pre-Norwood intervention. Twenty-eight atrial septostomies were performed: 23 static balloon dilations, 4 Rashkind septostomies, and 1 intra-atrial stent. Two procedures were aborted due to perforation (n = 1) or inability to enter the LA (n = 1). Eight total patients required surgical septectomy, for a failure rate of 27%. There were no catheter-related mortalities, although two patients died within 36 hr of the procedure after surgical septectomy. Major complications occurred in three patients (10%)--atrial perforations requiring intervention. Mean atrial septal defect gradient fell from 16.7 +/- 4.9 to 6.3 +/- 3.4 mm Hg (P < 0.001; n = 18). Mean LA pressure dropped from 21.8 +/- 5.5 to 13.1 +/- 6.5 mm Hg (P < 0.001; n = 16). Mean PaO(2) rose from 29.5 +/- 9.1 to 36.5 +/- 5.1 torr (P < 0.001; n = 23). Seventeen of 30 patients (57%) survived to discharge from Norwood. Thirteen have undergone hemi-Fontan and nine Fontan. Sixteen of 22 successful decompressions (73%) survived to discharge. Transcatheter decompression of the LA for patients with HLHS and rAS can be performed safely, reduces the transatrial gradient, and improves oxygenation. Catheter intervention improves survival compared to historical controls undergoing emergent Norwood.
机译:患有发育不良的左心综合征(HLHS)和房间隔狭窄(rAS)的婴儿出现紫osis,肺水肿,病危。我们机构的先前报告显示,用于Norman HLHS和rAS的新兴Norwood生存率为10%。我们假设采用rAS的HLHS经导管左心房(LA)减压将安全有效地缓解LA高血压,改善氧合作用并改善Norwood生存率。在1996年至2004年之间,对30名HLHS和rAS患者进行了心脏导管检查,以进行Norwood手术前的干预。进行了二十八例房间隔切开术:23例静态球囊扩张术,4例Rashkind切开术和1例房内支架。由于穿孔(n = 1)或无法进入LA(n = 1),两个程序被中止。共有8例患者需要行外科隔壁切除术,失败率为27%。尽管有两名患者在手术后的隔壁切除术后36小时内死亡,但没有导管相关的死亡率。三例患者(10%)发生了严重并发症-需要进行干预的心房穿孔。平均房间隔缺损梯度从16.7 +/- 4.9降至6.3 +/- 3.4 mm Hg(P <0.001; n = 18)。平均LA压力从21.8 +/- 5.5降至13.1 +/- 6.5毫米汞柱(P <0.001; n = 16)。平均PaO(2)从29.5 +/- 9.1升至36.5 +/- 5.1托(P <0.001; n = 23)。 30例患者中有17例(57%)幸存下来,从诺伍德医院康复。十三个半丰坦和九个丰坦经历了。 22次成功减压中的16次(73%)幸免于难。可以安全地对患有HLHS和rAS的患者进行LA的经导管减压,降低经房梯度,并改善氧合。与进行紧急诺伍德手术的历史对照相比,导管介入可提高生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号